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1. Introduction
  Persistent hyperglycemia induces the formation of reactive 
oxygen species (ROS) and advanced glycation endproducts 
(AGE), elevates the activity of aldose reductase, and activates 
protein kinase C isoforms, all of which play a key role in 
the pathogenesis of many long-term diabetic complications 
such as retinopathy, cataractogenesis, nephropathy and 
neuropathy[1]. In particular, increased formation of AGE 
due to prolonged hyperglycemia and carbonyl stress in 
diabetes and their subsequent accumulation in various 
tissues has been implicated in the pathogenesis of many 
diseases, including atherosclerosis, cardiac dysfunction, 
and vascular inflammation[2,3]. AGE are a chemically 
heterogeneous group of compounds formed in the Maillard 
reaction or browning reaction, when reducing sugars react 
non-enzymatically with amine residues, predominantly 
lysine and arginine, on proteins, lipids, and nucleic 
acids, ultimately leading to their chemical modification[4]. 
Recently, AGE formation has drawn considerable attention 
due to its involvement in the development of vascular 
complications during atherogenesis. During AGE generation, 
highly reactive oxygen/nitrogen species and dicarbonyl 
compounds are produced as intermediates that may attack 
numerous biomolecules. AGE also contribute to tissue 
injury by altering extracellular matrix structures through 
the formation of protein cross-links and modifying short-
lived intracellular proteins such as metabolic enzymes and 
mitochondrial protein complexes[5]. These observations led 
to the development of numerous AGE inhibitors with diverse 
Objective: To evaluate inhibitory potential of seven Korean thistles against the advanced 
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Among the seven Korean thistles, the leaves of Cirsium maackii (C. maackii) exhibited the most 
significant inhibitory activity against AGE formation. By means of bioassay-directed fractionation, 
a lignan, chlorogenic acid and 14 flavonoids were isolated from the active ethyl acetate soluble 
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been previously isolated; however, a lignan and 13 known compounds were isolated for the first 
time from C. maackii leaves in this study. Most of the isolated compounds exhibited inhibitory 
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potent AGE inhibitor with an IC50 value of 21.21 毺mol/L. Most importantly, two major flavonoids, 
luteolin and its 5-O-glucoside, also significantly inhibited AGE formation, with IC50 values of 
36.33 and 37.47 毺mol/L, respectively. Structure activity relationship revealed that the presence of 
free 3' and 4' dihydroxyl group in flavonoids skeleton played an important role in AGE inhibition. 
Conclusions: These results indicate that C. maackii and C. maackii-derived flavonoids might be 
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their significant inhibitory activity against AGE formation.
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chemical structures for use as possible therapeutic agents. 
Recently, there has been a growing interest in alternative 
therapies, especially in the therapeutic use of plant-derived 
natural products for the management of diabetes due to 
lower toxicity and fewer side effects than synthetic drugs. 
  Thistles, all members of the Compositae family, are 
perennial plants, 0.5-2.0 m in height, possessing lance-
shaped, spiny-toothed leaves and white to purple flowers. 
The thistles grow abundantly in Korea, Japan, and China[6,7]. 
Thus far, 250 species of thistles have been identified 
worldwide, and about 10 of these species have been found 
in Korea[8]. Because thistle has been used in traditional 
folk medicine as a diuretic, antiphlogistic, hemostatic, and 
detoxifying agent[9,10], most thistles have been surveyed by 
phytochemists and pharmacologists. Especially, milk thistle 
is one of the most popular herbal remedies used by patients 
with liver disease[11]. A great deal of research has been 
conducted regarding the flavonoids harbored by thistles, and 
a variety of activities are exhibited by these species[12-15]. 
  Previously, we reported that there is a correlation between 
antioxidant activity and the HPLC profiles of several Korean 
thistles[16], and the rat lens aldose reductase inhibitory 
activity of C. maackii and its major active constituents[17]. As 
a part of our ongoing search for anti-diabetic agents derived 
from natural sources, we investigated the AGE formation 
inhibitory activities of seven Korean thistles including 
Cirsium chanroenicum (C. chanroenicum), Cirsium lineare (C. 
lineare), Cirsium maackii (C. maackii), Cirsium nipponicum 
(C. nipponicum), Cirsium pendulum (C. pendulum), Cirsium 
setidens (C. setidens), and Carduus crispus (C. crispus) 
and identified compounds responsible for AGE inhibitory 
activities from the most active species. 
2. Materials and methods
2.1. General experimental procedures
  The 1H- and 13C-NMR spectra were measured using a 
JEOL JNM ECP-400 spectrometer (JEOL, Japan) at 400 MHz 
for 1H and 100 MHz for 13C. Column chromatography was 
performed using silica (Si) gel 60 (70-230 mesh, Merck, 
Darmstadt, Germany) and Sephadex LH-20 (20-100 毺m,
Sigma, St. Louis, MO, USA). All TLC analyses were 
conducted on precoated Merck Kieselgel 60 F254 plates
(20 cm伊20 cm, 0.25 mm, Merck) using 50% H2SO4 as a spray 
reagent.
2.2. Plant extracts 
  Methanolic extracts of C. lineare collected in September 
2002, C. chanroenicum in September 2003, C. setidens in 
September 2001, C. nipponicum in August 2001, C. pendulum 
in July 2003, and C. crispus in May 2005, were purchased 
from the Korean Plant Extract Bank under the Korea 
Research Institute of Bioscience and Biotechnology, Korea 
in February 2006. Whole C. maackii plants were collected in 
Ulsan, Republic of Korea, in August 2007. The plants were 
authenticated by a specialist in Cirsium taxonomy, Dr. Y. 
Kadota at the Department of Botany, National Museum of 
Nature and Science in Tsukuba, Japan. Each whole plant 
was separated into flowers, leaves, roots, and stem and dried 
in the shade for a week. A whole plant was registered and 
deposited as a voucher specimen at the herbarium of the 
National Museum of Nature and Science in Tsukuba, Japan 
as well as at the Department of Food Science and Nutrition, 
Pukyong National University (Professor J.S. Choi).
2.3. Chemicals and reagents
  Bovine serum albumin (BSA) ,  aminoguanidine 
hydrochloride, D-(-)-fructose, D-(+)-glucose, and dimethyl 
sulfoxide (DMSO) were purchased from Sigma Chemical 
Co. (St. Louis, MO, USA). Sodium azide was purchased from 
Junsei Chemical Co. (Tokyo, Japan). All solvents used were 
purchased from Merck, Duksan Pure Chemical Co., unless 
stated otherwise.
2.4. Extraction, fractionation and isolation
  The powder from leaves of C. maackii (1.28 kg) was 
refluxed with methanol (MeOH) for 3 h (4 L伊5). The total 
filtrate was then concentrated and dried in vacuo at 40 曟 in 
order to render the MeOH extract (316.3 g). This extract was 
suspended in distilled water and successively partitioned 
with methylene chloride (CH2Cl2), ethyl acetate (EtOAc), and 
n-butanol (n-BuOH) to yield the CH2Cl2 (68.8 g), EtOAc (80.6 g),
and n-BuOH (30.7 g) fractions, respectively, as well as an 
aqueous residue (125.8 g). The EtOAc fraction (80.0 g) was 
first chromatographed over a silica gel column (8 cm伊80 cm) 
using a mixed solvent of CH2Cl2 and MeOH (CH2Cl2:MeOH = 
20:1 to 1:1, v:v, gradient) to afford 16 subfractions (F01-F16). 
Compounds apigenin (22 mg), luteolin (10.5 g) and quercetin 
(28 mg) were separately purified from EF01 (0.8 g), EF03 (13.9 g),
and EF04 (0.5 g), respectively, with a solvent mixture of 
n-hexane and EtOAc (n-hexane:EtOAc = 8:1. v:v). Silica 
gel column chromatography of combined EF05 (2.38 g) and 
EF06 (2.43 g) using identical solvent conditions led to the 
isolation of apigenin 7-O-glucuronide methyl ester (48 mg),
cernusoside (56 mg) and apigenin 7-O-glucuronide (27 mg).
Compounds luteolin 5-O-glucoside (18.0 g), luteolin 7-O-
glucoside (35 mg), tracheloside (16 mg), diosmin (230 mg), 
naringenin 5-O-glucoside (25 mg), eriodictyol 5-O-
glucoside (15 mg), and luteolin 4’-O-glucoside (23 mg) 
were purified from EF08 (28.2 g), EF09 (0.5 g), and combined 
EF10 (1.5 g), EF11 (1.3 g) and EF12 (1.2 g) on Sephadex 
LH-20 columns (100% MeOH), respectively. Repeated 
chromatography of EF14 (1.1 g) over a silica gel column with 
CH2Cl2:MeOH:H2O (26:14:4, v:v) afforded quercetin 3-O-
glucoside (130 mg). Fraction EF13 (3.0 g) was recrystallized 
from 100% MeOH, yielding chlorogenic acid (350 mg). The 
combined EF14 and EF15 (7.4 g) was then chromatographed 
over a silica gel column with CH2Cl2:MeOH:H2O (26:14:4, 
v:v) to give rutin (450 mg). The isolated compounds were 
identified and characterized by different spectroscopic 
methods, including 1H- and 13C-NMR as well as by 
comparisons with published spectral data and TLC analyses. 
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2.5. Inhibition of AGE formation
  Inhibition of AGE formation was determined according to 
the modified method of Vinson and Howard[18]. To prepare 
the AGE reaction solution, 10 mg/mL BSA in 50 mmol/L
sodium phosphate  buf fer  (pH 7 .4 ) ,  wi th  0 .2  g /L
sodium azide to prevent bacterial growth, was added to
0.2 mol/L fructose and 0.2 mol/L glucose. The reaction 
mixture  ( 950  毺L )  was  then mixed wi th  var ious 
concentrations of the samples (50 毺L, final concentration: 
0.20-200.00 毺g/mL for the extracts and compounds; and 
0.10-100.00 毺g/mL for the fractions) dissolved in 10% (v/v)
DMSO. After incubation at 37 曟 for 7 d, the fluorescence 
intensity of the reaction products was determined using a 
spectrofluorometric detector (FLx800 microplate fluorescence 
reader, Bio-Tek Instruments, Inc., Winooski, VT, USA), 
with respective excitation and emission wavelengths at 
350 and 450 nm. The percent inhibition of AGE formation 
was determined from a graphical plot of the data and 
is expressed as the mean依SEM (triplicate experiments). 
Aminoguanidine, a nucleophilic hydrazine compound, was 
used as a reference compound in the AGE assay.
2.6. Statistical analysis
  Statistical significance was analyzed using one-way 
ANOVA and Student’s t-test (Systat In., Evanston, IL., USA), 
with P<0.01 considered to be statistically significant. All 
results are expressed as mean依SEM from three experiments.
3. Results
3.1. AGE formation inhibitory activities of the selected Korean 
thistles
  The inhibitory activities of the MeOH extracts of the tested 
Korean thistles on AGE formation were investigated. The 
MeOH extracts from the roots, whole plants, stem, and 
leaves of the same C. maackii exerted good inhibitory 
activities against AGE formation, with IC50 values of 
(129.31依5.29), (114.23依7.04), (62.74依1.41), and (28.20依0.84) 
毺g/mL, respectively, which are comparable to the IC50 
value of (149.04依11.27) 毺g/mL for the positive control, 
aminoguanidine (128.08 毺g/mL). The inhibitory activity 
increased in the order of leaves > stem > whole plants > 
roots of the same C. maackii plant. In contrast, the MeOH 
extracts from the C. maackii flower, from the whole C. 
crispus, C. nipponicum, C. pendulum, C. lineare, and C. 
setidens plants, and both the aerial and underground parts 
of C. chanroenicum did not show any inhibitory activity at 
concentrations up to 200.00 毺g/mL. 
3.2. AGE formation inhibitory activities of different solvent 
soluble fractions of C. maackii
  Because the MeOH extract of C. maackii had marked AGE 
inhibitory activity, we partitioned the extract with several 
solvents and further assessed the AGE inhibitory activity of 
the fractions at concentrations ranging from 1.00 to 100.00 
毺g/mL. The EtOAc and n-BuOH fractions among the 
several solvent-soluble fractions obtained from the MeOH 
extract showed significant AGE inhibitory activities with IC50 
values of (2.78依0.04) and (87.84依4.91) 毺g/mL, respectively, 
compared to aminoguanidine with the IC50 value of (128.08依6.89) 
毺g/mL. However, the CH2Cl2 and H2O fractions did not show 
any activity at the test concentrations.
3.3. AGE formation inhibitory activities of the isolated 
compounds from C. maackii
  Since the EtOAc fraction was found as the most active 
fraction, it was selected for chromatography in order to 
isolate active compounds. Repeated chromatography of 
the EtOAc fraction yielded 16 compounds, including a 
lignan, chlorogenic acid, and 14 flavonoids. The AGE 
formation inhibitory activities of the compounds isolated 
from C. maackii are summarized in the Table 1. As shown 
in the Table 1, most of the isolated compounds exhibited 
promising AGE formation inhibitory activities. Among them, 
cernuoside was shown to be the most potent AGE inhibitor 
followed by luteolin 7-O-glucoside and quercetin with 
their respective IC50 values of (21.21依0.25), (24.22依0.29) 
and (24.35依0.95) 毺mol/L, compared to the positive control 
aminoguanidine. In addition, chlorogenic acid, luteolin and 
its glycosides, quercetin 3-O-glucoside, and rutin also 
showed strong inhibitory activities against AGE formation. 
Interestingly, although apigenin showed weak inhibitory 
activity, its two glycosides, apigenin 7-O-glucuronide 
methyl ester and apigenin 7-O-glucuronide, did not show 
inhibitory activity at the concentration tested. 
Table 1
Inhibition of AGE formation by compounds isolated from EtOAc 
fraction of C. maackii leaves.
Compounds IC50 (毺g/mL) 
a IC50 (毺M) 
b
Apigenin (1) 152.52依6.95    564.89依25.72
Luteolin (2)   10.40依0.03      36.33依0.10
Quercetin (3)     7.35依0.29      24.35依0.95
Apigenin7-O-glucuronide methyl 
ester (4)
      >200 -
Cernuoside (5)    9.50依0.11      21.21依0.25
Apigenin 7-O-glucuronide (6)       >200         -
Luteolin 5-O-glucoside (7)   16.80依0.13      37.47依0.29
Luteolin 7-O-glucoside (8)   10.85依0.13      24.22依0.29
Tracheloside (9)      >200              -
Diosmin (10)   41.20依0.56    137.21依1.87
Naringenin 5-O-glucoside (11)   45.25依0.99    104.26依2.28
Eriodictyol 5-O-glucoside (12)   28.77依0.66      63.93依1.47
Luteolin 4'-O-glucoside (13)   15.24依0.07      33.87依0.16
Quercetin 3-O-glucoside (14)   18.80依0.43      47.00依1.13
Chlorogenic acid (15)   10.36依0.01      29.28依0.04
Rutin (16)   31.99依0.74      52.44依1.22
Aminoguanidine 129.36依1.60 1 170.15依14.47
aTest concentrations of samples were 0.20-200.00 毺g/mL dissolved 
in DMSO. IC50 is expressed as the mean依SEM from triplicate 
experiments.  
bAminoguanidine was used as a positive control.
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4. Discussion
  Persistent hyperglycemia induces increased formation of 
AGE, which has been implicated in the onset of diabetic 
complications. In this point of view, we investigated the 
AGE formation inhibitory activities of the selected Korean 
thistles using an in vitro AGE formation inhibitory assay. 
Interestingly, only different parts of C. maackii, which was 
previously found to be a good inhibitor of rat lens aldose 
reductase, exhibited potent inhibitory activities against 
AGE formation. The significant variability in AGE inhibitory 
activities between Cirsium species or even between parts of 
the same plant might result from differences in the active 
components between species and different parts of the same 
plant, leading to variation in the inhibitory effect on diabetic 
complications. Therefore, the present study was designed 
to identify the active compounds responsible for potent 
AGE inhibitory activity of C. maackii in addition to the 
relationship between their structure and function.
  Solvent partitioning of the MeOH extract of C. maackii 
yielded four subfractions, among which EtOAc and n-BuOH 
fractions showed significant AGE inhibitory activities. 
However, the CH2Cl2 and H2O fractions did not show any 
activity at the test concentrations. It is interesting to note 
that both EtOAc and n-BuOH fractions had marked AGE 
inhibitory activity, whereas the other fractions showed weak 
or no activities at the tested concentrations. Plants possess a 
range of nonpolar to polar phytochemicals. The comparative 
inhibitory activities of several fractions derived from the 
MeOH extract of C. maackii leaves can be explained by 
their compositional differences. Flavonoids were expected 
to be present in large amounts in the polar EtOAc and 
n-BuOH fractions. From a health point of view, this may be 
meaningful to consumers because most of the components 
in the EtOAc and n-BuOH fractions are easily dissolved 
in water. In the present study, from the most active EtOAc 
fraction of the MeOH extract of the C. maackii leaves, a 
lignan, chlorogenic acid, and 14 known flavonoids were 
isolated through repeated column chromatography and were 
subsequently characterized by 1H- and 13C-NMR, DEPT, 
HMQC, and HMBC, as well as comparisons with published 
spectral data. luteolin and its 5-O-glucoside had been 
previously isolated, however, a lignan, along with 13 known 
compounds were isolated from C. maackii leaves for the first 
time in this study[19-30].
  Besides apigenin, luteolin, quercetin, apigenin 7-glucuronide 
and its methyl ester, chlorogenic acid and rutin were 
previously described as AGE inhibitors, cernuoside, luteolin 
4’, 5 or 7-O-glucoside, diosmin, naringenin 5-glucoside, 
eriodictyol 5-glucoside, quercetin 3-glucoside tested in our 
study showed concentration-dependent inhibitory activity 
against AGE formation for the first time. Although apigenin 
and diosmin had weak activities at the tested concentrations, 
the order of AGE inhibitory activity of most active flavonoids 
was similar, with IC50 values ranging from 21.21 to 52.44 毺mol/L.
Structural comparisons of these flavonoids and their 
inhibitory activities clearly show that the ortho-dihydroxy 
function of the B ring in the flavonoid skeleton, as evidenced 
by luteolin, quercetin, and their glycosides including rutin, 
quercetin 3-glucoside, and luteolin 5 or 7-O-glucoside, 
plays a pivotal role in the observed inhibitory activity. When 
such an O-dihydroxyl group was absent (i.e., apigenin and 
its glycosides), weak inhibitory activity was observed. The 
mechanism by which flavonoids inhibit AGE formation 
has yet to be established. The basic structure of flavonoids 
and other structural factors is important in the inhibitory 
mechanism. Muthenna et al. suggested the following two 
possible mechanisms for flavonoid-induced inhibition of 
AGE formation: (i) it scavenges free radicals directly or (ii) 
it chelates the metal ions by forming complexes with them 
and thereby partly inhibits post-Amadori formation[31]. It 
was also reported that protein glycation was accompanied 
by oxidative reactions[32]. Yim et al. has also suggested that 
glycation of albumin leads to the increased production of 
ROS[33]. Jung et al. demonstrated that the presence of an 
ortho-hydroxyl group on the B-ring plays an important 
role in the antioxidant activity in the total ROS system[17]. 
Similar trends were observed in flavonoid-induced 
inhibitory activity against AGE formation in the present 
study. Considering present and previous results on ROS 
inhibition of flavonoids[17,34], it appears that the inhibitory 
mechanism of flavonoids against glycation is at least 
partly due to antioxidant activity. Flavonoids are of current 
interest in research due to the important biological and 
pharmacological properties attributed to their antioxidant 
properties[35]. Our results indicate several major flavonoids 
exhibit significant AGE inhibitory potential. According to 
previous research, two key flavonoids, luteolin and luteolin 
5-O-glucoside inhibit RLAR activity and the generation of 
ROS[34]. Our previous comparative HPLC analysis of different 
kinds of thistles devoid of AGE inhibitory activity revealed 
the absence of these compounds[16], indicating luteolin 
derivatives may play a role in the ability of C. maackii to 
inhibit diabetic complications. 
  Since a study comparing the ability of thistles to inhibit 
diabetic complications has not yet been reported, we studied 
the ability of some Korean thistles to inhibit AGE formation 
and isolated the active components from C. maackii, the 
most promising AGE inhibitory thistle found in the study. In 
conclusion, these previous data, together with our present 
results from AGE assays, indicate that C. maackii and C. 
maackii-derived flavonoids could be promising therapeutic 
agents for preventing diabetic complications. Based on the 
in vitro results, further experiments are needed to clarify the 
mechanisms of C. maackii and its flavonoids in vivo.
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